Detalhe da pesquisa
1.
FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR.
Nature
; 471(7339): 523-6, 2011 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21430781
2.
Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer.
BMC Cancer
; 16: 312, 2016 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27179511
3.
Screening for epidermal growth factor receptor mutations in lung cancer.
N Engl J Med
; 361(10): 958-67, 2009 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-19692684
4.
mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients.
J Transl Med
; 9: 163, 2011 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21951562
5.
Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in advanced nonsmall-cell lung cancer.
Curr Opin Oncol
; 22(2): 112-20, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19949333
6.
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.
J Transl Med
; 8: 135, 2010 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-21167064
7.
Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies.
Drug News Perspect
; 23(10): 655-61, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21180651
8.
Biomarkers in lung oncology.
Pulm Pharmacol Ther
; 23(6): 508-14, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20471486
9.
Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer.
Mol Cancer Ther
; 8(1): 194-202, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19139129
10.
XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression.
Clin Lung Cancer
; 10(1): 47-52, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19289372
11.
A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma.
Clin Cancer Res
; 14(17): 5565-70, 2008 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18765549
12.
Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung.
Clin Cancer Res
; 14(15): 4794-9, 2008 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18676750
13.
IL-6/gp130/STAT3 signaling axis in cancer and the presence of in-frame gp130 somatic deletions in inflammatory hepatocellular tumors.
Future Oncol
; 5(3): 305-8, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19374537
14.
PIK3CA mutations and BRCA1 expression in breast cancer: potential biomarkers for chemoresistance.
Cancer Invest
; 26(10): 1044-51, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18798071
15.
BRCA1: a new genomic marker for non-small-cell lung cancer.
Clin Lung Cancer
; 9(6): 331-9, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19073515
16.
Translational research in glioblastoma multiforme: molecular criteria for patient selection.
Future Oncol
; 4(2): 219-28, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18407735
17.
[Molecular biology of castration resistant prostate cancer.] / Biología molecular del cáncer de próstata resistente a la castración.
Arch Esp Urol
; 71(8): 639-650, 2018 Sep.
Artigo
em Espanhol
| MEDLINE | ID: mdl-30319124
18.
Gene expression and polymorphisms of DNA repair enzymes: cancer susceptibility and response to chemotherapy.
Clin Lung Cancer
; 8(6): 369-75, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17562237
19.
Epidermal growth factor receptor activation: how exon 19 and 21 mutations changed our understanding of the pathway.
Clin Cancer Res
; 12(24): 7222-31, 2006 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17189393
20.
Predicting the outcome of chemotherapy for lung cancer.
Curr Opin Pharmacol
; 6(4): 323-31, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16765644